Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Amgen
Sponsor:
Collaborator:
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01345019
First received: April 28, 2011
Last updated: July 23, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid in the treatment of bone disease from multiple myeloma.


Condition Intervention Phase
Cancer
Hematologic Malignancies
Multiple Myeloma
Oncology
Bone Metastases
Multiple Myeloma Bone Lesions
Drug: Denosumab
Drug: Zoledronic acid
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects With Newly Diagnosed Multiple Myeloma

Resource links provided by NLM:


Further study details as provided by Amgen:

Primary Outcome Measures:
  • Time to the first on-study skeletal related event (SRE) (non-inferiority test) [ Time Frame: Approximately 48 months ] [ Designated as safety issue: No ]
    Until approximately 800 subjects have experienced at least one on-study SRE (anticipated to be approximately 48 months).


Secondary Outcome Measures:
  • Time to the first-and-subsequent SRE (superiority test, using multiple event analysis) [ Time Frame: Approximately 48 months ] [ Designated as safety issue: No ]
    Until approximately 800 subjects have experienced at least one on-study SRE (anticipated to be approximately 48 months)

  • Time to the first on-study SRE (superiority test) [ Time Frame: Approximately 48 months ] [ Designated as safety issue: No ]
    Until approximately 800 subjects have experienced at least one on-study SRE (anticipated to be approximately 48 months)


Estimated Enrollment: 1520
Study Start Date: May 2012
Estimated Study Completion Date: October 2018
Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Zoledronic acid 4 mg IV and Placebo SC
Zoledronic acid 4 mg (adjusted for renal function) IV over at least 15 minutes + Placebo SC Q4W (n = 760)
Drug: Zoledronic acid
Zoledronic acid 4 mg (adjusted for renal function) IV over at least 15 minutes Q4W (n = 760)
Experimental: Denosumab 120 mg SC and Placebo IV
Denosumab 120 mg SC + Placebo IV over at least 15 minutes Q4W (n = 760)
Drug: Denosumab
Denosumab 120 mg SC

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Documented evidence of multiple myeloma
  • Monoclonal plasma cells in the bone marrow greater than or equal to 10% and/or presence of a biopsy-proven plasmacytoma
  • Monoclonal protein present in the serum and/or urine
  • Radiographic (ie, X-ray, or computer tomography [CT]) evidence of at least 1 lytic bone lesion (or at least 1 focal lesion per magnetic resonance imaging [MRI])
  • Plan to receive or is receiving primary frontline anti-myeloma therapies
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2
  • Written informed consent before any study-specific procedure is performed

Exclusion Criteria:

  • Nonsecretory multiple myeloma based upon standard M-component criteria (ie, measurable serum/urine M-component) unless the baseline serum free light chain level is elevated
  • POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
  • Plasma cell leukemia
  • More than 30 days of previous treatment (before screening) with anti-myeloma therapy (does not include radiotherapy or a single short course of steroid [ie, less than or equal to the equivalent of dexamethasone 60 mg/day for 4 days]).
  • Planned radiation therapy or surgery to the bone (does not include procedures performed before randomization)
  • Prior administration of denosumab
  • More than 1 previous dose of IV bisphosphonate administration
  • Use of oral bisphosphonates with a cumulative exposure of more than 1 year
  • Prior history or current evidence of osteonecrosis/osteomyelitis of the jaw
  • Active dental or jaw condition which requires oral surgery, including tooth extraction
  • Non-healed dental/oral surgery, including tooth extraction
  • Planned invasive dental procedures
  • Subject is pregnant or breast feeding, or planning to become pregnant within 7 months after end of treatment
  • Subject has known sensitivity to any of the products to be administered during the study (eg, mammalian derived products, calcium or vitamin D)
  • Other criteria may apply
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01345019

Contacts
Contact: Amgen Call Center 866-572-6436

  Hide Study Locations
Locations
United States, Arizona
Research Site Recruiting
Tucson, Arizona, United States, 85704
United States, Arkansas
Research Site Recruiting
Fayetteville, Arkansas, United States, 72703
United States, California
Research Site Recruiting
Anaheim, California, United States, 92801
Research Site Recruiting
Campbell, California, United States, 95008
Research Site Recruiting
Fresno, California, United States, 93720
Research Site Recruiting
Pleasant Hill, California, United States, 94523
Research Site Recruiting
Santa Barbara, California, United States, 93105
Research Site Completed
Santa Maria, California, United States, 93454
United States, District of Columbia
Research Site Recruiting
Washington, District of Columbia, United States, 20010
Research Site Completed
Washington, District of Columbia, United States, 20007
United States, Florida
Research Site Recruiting
Boynton Beach, Florida, United States, 33426
Research Site Completed
Boynton Beach, Florida, United States, 33435
Research Site Recruiting
Jacksonville, Florida, United States, 32256
United States, Georgia
Research Site Completed
Columbus, Georgia, United States, 31904
Research Site Recruiting
Savannah, Georgia, United States, 31405
United States, Illinois
Research Site Recruiting
Chicago, Illinois, United States, 60612
Research Site Recruiting
Joliet, Illinois, United States, 60435
Research Site Recruiting
Maywood, Illinois, United States, 60153
Research Site Completed
Niles, Illinois, United States, 60714
Research Site Recruiting
Skokie, Illinois, United States, 60076
Research Site Recruiting
Skokie, Illinois, United States, 60077
United States, Indiana
Research Site Recruiting
Anderson, Indiana, United States, 46016
Research Site Recruiting
Fort Wayne, Indiana, United States, 46845
Research Site Recruiting
Indianapolis, Indiana, United States, 46202
United States, Iowa
Research Site Recruiting
Ames, Iowa, United States, 50010
Research Site Recruiting
Iowa City, Iowa, United States, 52242
United States, Kentucky
Research Site Recruiting
Paducah, Kentucky, United States, 42003
United States, Louisiana
Research Site Completed
New Orleans, Louisiana, United States, 70121
United States, Maine
Research Site Recruiting
Scarborough, Maine, United States, 04074
United States, Maryland
Research Site Recruiting
Baltimore, Maryland, United States, 21229
Research Site Recruiting
Baltimore, Maryland, United States, 21237
Research Site Recruiting
Baltimore, Maryland, United States, 21204
Research Site Recruiting
Bethesda, Maryland, United States, 20817
Research Site Recruiting
Westminster, Maryland, United States, 21157
United States, Massachusetts
Research Site Recruiting
Boston, Massachusetts, United States, 02114
Research Site Recruiting
Boston, Massachusetts, United States, 02215
Research Site Recruiting
Danvers, Massachusetts, United States, 01923
Research Site Recruiting
Fairhaven, Massachusetts, United States, 02719
United States, Michigan
Research Site Completed
Detroit, Michigan, United States, 48201
Research Site Recruiting
Lansing, Michigan, United States, 48910
United States, Mississippi
Research Site Recruiting
Jackson, Mississippi, United States, 39216
United States, Missouri
Research Site Recruiting
Springfield, Missouri, United States, 65807
United States, Montana
Research Site Recruiting
Billings, Montana, United States, 59101
United States, Nebraska
Research Site Recruiting
Lincoln, Nebraska, United States, 68506
Research Site Recruiting
Omaha, Nebraska, United States, 68198
United States, Nevada
Research Site Recruiting
North Las Vegas, Nevada, United States, 89086
United States, New Jersey
Research Site Completed
Hackensack, New Jersey, United States, 07601
United States, New York
Research Site Recruiting
Lake Success, New York, United States, 11042
Research Site Recruiting
New York, New York, United States, 10021
Research Site Recruiting
Rochester, New York, United States, 14621
United States, North Carolina
Research Site Completed
Fayetteville, North Carolina, United States, 28304
Research Site Recruiting
Goldsboro, North Carolina, United States, 27534
Research Site Recruiting
High Point, North Carolina, United States, 27262
United States, North Dakota
Research Site Completed
Bismarck, North Dakota, United States, 58501
United States, Oklahoma
Research Site Recruiting
Oklahoma City, Oklahoma, United States, 73120-8345
United States, Pennsylvania
Research Site Recruiting
Hershey, Pennsylvania, United States, 17033
Research Site Completed
Philadelphia, Pennsylvania, United States, 19140
Research Site Recruiting
Philadelphia, Pennsylvania, United States, 19106
Research Site Recruiting
Philadelphia, Pennsylvania, United States, 19141
Research Site Recruiting
West Reading, Pennsylvania, United States, 19611
United States, South Carolina
Research Site Recruiting
Charleston, South Carolina, United States, 29406
Research Site Recruiting
Charleston, South Carolina, United States, 29414
Research Site Recruiting
Greenville, South Carolina, United States, 29615
United States, South Dakota
Research Site Recruiting
Aberdeen, South Dakota, United States, 57401
Research Site Recruiting
Rapid City, South Dakota, United States, 57701
Research Site Recruiting
Sioux Falls, South Dakota, United States, 57105
United States, Tennessee
Research Site Recruiting
Memphis, Tennessee, United States, 38120
United States, Texas
Research Site Recruiting
Houston, Texas, United States, 77030
Research Site Recruiting
Lubbock, Texas, United States, 79415
United States, Utah
Research Site Recruiting
Salt Lake City, Utah, United States, 84106
United States, Virginia
Research Site Recruiting
Christiansburg, Virginia, United States, 24073
United States, Washington
Research Site Recruiting
Spokane, Washington, United States, 99208
Research Site Completed
Tacoma, Washington, United States, 98405
United States, West Virginia
Research Site Recruiting
Morgantown, West Virginia, United States, 26506
United States, Wisconsin
Research Site Recruiting
Green Bay, Wisconsin, United States, 54311
Research Site Completed
Minocqua, Wisconsin, United States, 54548
Australia, New South Wales
Research Site Recruiting
Liverpool, New South Wales, Australia, 2170
Research Site Recruiting
Tweed Heads, New South Wales, Australia, 2485
Australia, Queensland
Research Site Recruiting
Douglas, Queensland, Australia, 4814
Research Site Recruiting
South Brisbane, Queensland, Australia, 4101
Australia, Tasmania
Research Site Recruiting
Hobart, Tasmania, Australia, 7000
Australia, Victoria
Research Site Recruiting
Clayton, Victoria, Australia, 3168
Research Site Recruiting
East Melbourne, Victoria, Australia, 3002
Research Site Recruiting
Epping, Victoria, Australia, 3076
Research Site Recruiting
Parkville, Victoria, Australia, 3050
Research Site Recruiting
Prahran, Victoria, Australia, 3181
Austria
Research Site Completed
Graz, Austria, 8036
Research Site Recruiting
Innsbruck, Austria, 6020
Research Site Recruiting
Krems an der Donau, Austria, 3500
Research Site Recruiting
Salzburg, Austria, 5020
Research Site Recruiting
Wels, Austria, 4600
Research Site Recruiting
Wien, Austria, 1140
Bulgaria
Research Site Recruiting
Pleven, Bulgaria, 5800
Research Site Recruiting
Plovdiv, Bulgaria, 4000
Research Site Recruiting
Sofia, Bulgaria, 1407
Research Site Recruiting
Sofia, Bulgaria, 1606
Research Site Recruiting
Sofia, Bulgaria, 1756
Research Site Recruiting
Varna, Bulgaria, 9010
Canada, British Columbia
Research Site Recruiting
Burnaby, British Columbia, Canada, V5G 2X6
Canada, Manitoba
Research Site Recruiting
Winnipeg, Manitoba, Canada, R3E 0V9
Canada, New Brunswick
Research Site Recruiting
Moncton, New Brunswick, Canada, E1C 6Z8
Canada, Newfoundland and Labrador
Research Site Recruiting
St. Johns, Newfoundland and Labrador, Canada, A1B 3V6
Canada, Ontario
Research Site Recruiting
Barrie, Ontario, Canada, L4M 6M2
Research Site Recruiting
Newmarket, Ontario, Canada, L3Y 2P9
Research Site Recruiting
Sault Ste. Marie, Ontario, Canada, P6B 0A8
Research Site Recruiting
Toronto, Ontario, Canada, M2K 1E1
Research Site Recruiting
Toronto, Ontario, Canada, M6R 1B5
Research Site Recruiting
Toronto, Ontario, Canada, M9N 1N8
Research Site Completed
Toronto, Ontario, Canada, M5B 1W8
Research Site Recruiting
Windsor, Ontario, Canada, N8W 2X3
Canada, Quebec
Research Site Recruiting
Laval, Quebec, Canada, H7M 3L9
Research Site Recruiting
Montreal, Quebec, Canada, H4J 1C5
Research Site Recruiting
Montréal, Quebec, Canada, H1T 2M4
Canada
Research Site Recruiting
Quebec, Canada, G1R 2J6
Czech Republic
Research Site Recruiting
Brno, Czech Republic, 625 00
Research Site Recruiting
Ostrava-Poruba, Czech Republic, 708 52
Research Site Recruiting
Plzen, Czech Republic, 304 60
Research Site Completed
Praha 10, Czech Republic, 100 34
Research Site Completed
Praha 2, Czech Republic, 128 08
France
Research Site Recruiting
Amiens Cedex 1, France, 80054
Research Site Recruiting
Avignon Cedex 9, France, 84902
Research Site Recruiting
Creteil, France, 94010
Research Site Recruiting
Le Kremlin Bicetre, France, 94270
Research Site Recruiting
Le Mans, France, 72000
Research Site Recruiting
Le Mans Cedex 9, France, 72037
Research Site Recruiting
Lille, France, 59037
Research Site Recruiting
Lyon Cédex 3, France, 69437
Research Site Recruiting
Marseille cedex 5, France, 13385
Research Site Recruiting
Marseille Cedex 9, France, 13272
Research Site Recruiting
Nantes Cedex 1, France, 44035
Research Site Completed
Nice Cedex 3, France, 06202
Research Site Completed
Paris, France, 75010
Research Site Completed
Paris, France, 75013
Research Site Recruiting
Paris, France, 75015
Research Site Recruiting
Paris Cedex 12, France, 75571
Research Site Recruiting
Paris Cedex 14, France, 75679
Research Site Completed
Pessac Cedex, France, 33604
Research Site Recruiting
Pierre-Benite cedex, France, 69495
Research Site Recruiting
Pontoise Cedex, France, 95301
Research Site Completed
Reims Cedex, France, 51056
Research Site Recruiting
Rouen, France, 76038
Research Site Recruiting
Saint Quentin, France, 02321
Research Site Recruiting
Strasbourg, France, 67000
Research Site Recruiting
Villefranche Sur Saone Cedex, France, 69400
Germany
Research Site Recruiting
Bonn, Germany, 53127
Research Site Completed
Chemnitz, Germany, 09113
Research Site Recruiting
Essen, Germany, 45239
Research Site Recruiting
Hamburg, Germany, 20246
Research Site Recruiting
Köln, Germany, 50924
Research Site Recruiting
Leipzig, Germany, 04103
Research Site Recruiting
Münster, Germany, 48149
Research Site Completed
Regensburg, Germany, 93049
Greece
Research Site Recruiting
Athens, Greece, 11527
Research Site Recruiting
Athens, Greece, 11525
Research Site Recruiting
Athens, Greece, 11528
Research Site Recruiting
Heraklion, Greece, 71110
Research Site Recruiting
Patra, Greece, 26500
Research Site Recruiting
Thessaloniki, Greece, 57010
Hong Kong
Research Site Recruiting
Hong Kong, Hong Kong
Research Site Recruiting
New Territories, Hong Kong
Hungary
Research Site Recruiting
Budapest, Hungary, 1097
Research Site Recruiting
Budapest, Hungary, 1083
Research Site Recruiting
Debrecen, Hungary, 4032
Research Site Recruiting
Gyula, Hungary, 5700
Research Site Recruiting
Kaposvar, Hungary, 7400
Research Site Recruiting
Szeged, Hungary, 6720
Ireland
Research Site Recruiting
Co-Limerick, Ireland
Research Site Recruiting
Dublin, Ireland, 7
Research Site Recruiting
Dublin, Ireland, 8
Research Site Recruiting
Dublin, Ireland, 24
Research Site Recruiting
Tullamore, Ireland
Italy
Research Site Recruiting
Ancona, Italy, 60126
Research Site Recruiting
Bari, Italy, 70124
Research Site Recruiting
Brescia, Italy, 25125
Research Site Recruiting
Catania, Italy, 95124
Research Site Recruiting
Firenze, Italy, 50134
Research Site Recruiting
Genova, Italy, 16132
Research Site Recruiting
Napoli, Italy, 80136
Research Site Recruiting
Napoli, Italy, 80131
Research Site Recruiting
Novara, Italy, 28100
Research Site Recruiting
Palermo, Italy, 90146
Research Site Completed
Pescara, Italy, 65124
Research Site Recruiting
Pisa, Italy, 56127
Research Site Recruiting
Roma, Italy, 00144
Research Site Recruiting
Roma, Italy, 00161
Research Site Completed
Rozzano MI, Italy, 20089
Research Site Recruiting
Torino, Italy, 10126
Research Site Recruiting
Udine, Italy, 33100
Research Site Recruiting
Vimercate MB, Italy, 20871
Japan
Research Site Recruiting
Nagoya-shi, Aichi, Japan, 457-8510
Research Site Recruiting
Akita-shi, Akita, Japan, 010-8543
Research Site Recruiting
Kamogawa-shi, Chiba, Japan, 296-8602
Research Site Recruiting
Fukuoka-shi, Fukuoka, Japan, 814-0180
Research Site Recruiting
Ogaki-shi, Gifu, Japan, 503-8502
Research Site Recruiting
Maebashi-shi, Gunma, Japan, 371-8511
Research Site Recruiting
Shibukawa-shi, Gunma, Japan, 377-8511
Research Site Recruiting
Kobe-city, Hyogo, Japan, 650-0047
Research Site Recruiting
Kumamoto-shi, Kumamoto, Japan, 860-0008
Research Site Recruiting
Kyoto-shi, Kyoto, Japan, 603-8151
Research Site Recruiting
Okayama-shi, Okayama, Japan, 701-1192
Research Site Recruiting
Kawagoe-shi, Saitama, Japan, 350-8550
Research Site Recruiting
Tokushima-shi, Tokushima, Japan, 770-8503
Research Site Recruiting
Shibuya-ku, Tokyo, Japan, 150-8935
Research Site Recruiting
Shinjuku-ku, Tokyo, Japan, 162-8655
Research Site Recruiting
Toyama-shi, Toyama, Japan, 930-8550
Korea, Republic of
Research Site Recruiting
Anyang, Korea, Republic of, 431-070
Research Site Recruiting
Busan, Korea, Republic of, 602-739
Research Site Recruiting
Daegu, Korea, Republic of, 700-721
Research Site Recruiting
Daejeon, Korea, Republic of, 301-721
Research Site Recruiting
Gwangju, Korea, Republic of, 519-763
Research Site Recruiting
Incheon, Korea, Republic of, 405-760
Research Site Recruiting
Seoul, Korea, Republic of, 135-710
Research Site Recruiting
Seoul, Korea, Republic of, 158-710
Research Site Recruiting
Seoul, Korea, Republic of, 110-744
Research Site Recruiting
Seoul, Korea, Republic of, 120-752
Research Site Recruiting
Seoul, Korea, Republic of, 137-701
Lithuania
Research Site Recruiting
Kaunas, Lithuania, 50009
Research Site Recruiting
Vilnius, Lithuania, LT-08661
Malaysia
Research Site Recruiting
Ipoh, Perak, Malaysia, 30990
Research Site Recruiting
Georgetown, Pinang, Malaysia, 10990
Research Site Recruiting
Kuching, Sarawak, Malaysia, 93586
Research Site Recruiting
Ampang, Malaysia, 68000
New Zealand
Research Site Recruiting
Christchurch, New Zealand, 8011
Research Site Recruiting
Grafton, Auckland, New Zealand, 1023
Poland
Research Site Recruiting
Legnica, Poland, 59-220
Research Site Recruiting
Lublin, Poland, 20-081
Research Site Recruiting
Slupsk, Poland, 76-200
Research Site Recruiting
Torun, Poland, 87-100
Research Site Recruiting
Warszawa, Poland, 02-097
Research Site Recruiting
Warszawa, Poland, 02-776
Research Site Recruiting
Wroclaw, Poland, 53-439
Portugal
Research Site Recruiting
Braga, Portugal, 4710-243
Research Site Recruiting
Coimbra, Portugal, 3000-075
Research Site Recruiting
Lisboa, Portugal, 1169-050
Research Site Recruiting
Matosinhos, Portugal, 4464-513
Research Site Recruiting
Porto, Portugal, 4200-072
Russian Federation
Research Site Recruiting
Ekaterinburg, Russian Federation, 620102
Research Site Recruiting
Moscow, Russian Federation, 115478
Research Site Recruiting
Nizhny Novgorod, Russian Federation, 603126
Research Site Recruiting
Novosibirsk, Russian Federation, 630051
Research Site Recruiting
Petrozavodsk, Russian Federation, 185019
Research Site Completed
Saint Petersburg, Russian Federation, 198205
Research Site Recruiting
Saint-Petersburg, Russian Federation, 193312
Research Site Recruiting
Saint-Petersburg, Russian Federation, 197110
Research Site Recruiting
Samara, Russian Federation, 443099
Research Site Recruiting
Saratov, Russian Federation, 410012
Research Site Recruiting
St. Petersburg, Russian Federation, 197022
Research Site Recruiting
Volgograd, Russian Federation, 400138
Singapore
Research Site Recruiting
Singapore, Singapore, 119228
Research Site Recruiting
Singapore, Singapore, 308433
Research Site Recruiting
Singapore, Singapore, 169608
Slovakia
Research Site Recruiting
Bratislava, Slovakia, 851 07
Research Site Recruiting
Nitra, Slovakia, 950 01
Research Site Recruiting
Nove Zamky, Slovakia, 940 34
Spain
Research Site Recruiting
Sevilla, Andalucía, Spain, 41013
Research Site Recruiting
Palma de Mallorca, Baleares, Spain, 07198
Research Site Recruiting
Salamanca, Castilla León, Spain, 37007
Research Site Recruiting
Badalona, Cataluña, Spain, 08916
Research Site Recruiting
Barcelona, Cataluña, Spain, 08036
Research Site Recruiting
Valencia, Comunidad Valenciana, Spain, 46026
Research Site Completed
Valencia, Comunidad Valenciana, Spain, 46017
Research Site Recruiting
Ourense, Galicia, Spain, 32005
Research Site Recruiting
San Sebastian, País Vasco, Spain, 20014
Research Site Recruiting
Madrid, Spain, 28006
Research Site Recruiting
Madrid, Spain, 28034
Switzerland
Research Site Recruiting
Basel, Switzerland, 4031
Research Site Recruiting
Chur, Switzerland, 7000
Research Site Recruiting
Zurich, Switzerland, 8038
Research Site Recruiting
Zurich, Switzerland, 8032
Taiwan
Research Site Recruiting
Changhua, Taiwan, 50006
Research Site Recruiting
Kaohsiung, Taiwan, 83301
Research Site Recruiting
Taichung, Taiwan, 407
Research Site Recruiting
Taichung, Taiwan, 40447
Research Site Recruiting
Tainan, Taiwan, 70403
Research Site Recruiting
Taipei, Taiwan, 10002
Research Site Recruiting
Taoyuan, Taiwan, 33305
Turkey
Research Site Recruiting
Ankara, Turkey, 06100
Research Site Recruiting
Istanbul, Turkey, 34452
Research Site Recruiting
Izmir, Turkey, 35340
Ukraine
Research Site Recruiting
Cherkasy, Ukraine, 18009
Research Site Recruiting
Dnipropetrovsk, Ukraine, 49102
Research Site Recruiting
Ivano-Frankivsk, Ukraine, 76008
Research Site Recruiting
Khmelnitskiy, Ukraine, 29000
Research Site Recruiting
Kyiv, Ukraine, 04107
Research Site Recruiting
Lviv, Ukraine, 79031
Research Site Recruiting
Poltava, Ukraine, 36024
United Kingdom
Research Site Recruiting
Harrow, United Kingdom, HA1 3UJ
Research Site Recruiting
Leeds, United Kingdom, LS9 7TF
Research Site Recruiting
London, United Kingdom, SW17 0RE
Research Site Recruiting
London, United Kingdom, NW3 2QG
Research Site Recruiting
Oxford, United Kingdom, OX3 7LJ
Sponsors and Collaborators
Amgen
Daiichi Sankyo Inc.
Investigators
Study Director: MD Amgen
  More Information

Additional Information:
No publications provided

Responsible Party: Amgen
ClinicalTrials.gov Identifier: NCT01345019     History of Changes
Other Study ID Numbers: 20090482
Study First Received: April 28, 2011
Last Updated: July 23, 2014
Health Authority: Switzerland: Swissmedic (Swiss Agency for Therapeutic Products)
Taiwan: Taiwan Provincial Department of Health
United Kingdom: Medicines and Healthcare Products Regulatory Agency
United States: Food and Drug Administration
Australia: Therapeutic Goods Administration
Czech Republic: State Institute for Drug Control
France: European Medicines Agency
France: Ministry of Health
Germany: Federal Institute for Drugs and Medical Devices
Greece: Ministry of Health & Social Solidarity, National Organization for Medicines
Hungary: National Institute of Pharmacy
Ireland: Irish Medicines Board
Italy: Ministry of Health
Japan: Pharmaceuticals and Medical Devices Evaluation Center
New Zealand: Medicines and Medical Devices Safety Authority
Poland: Central Ethics Committee
Poland: Ministry of Health
Portugal: Instituto Nacional da Farmácia e do Medicamento (INFARMED)
Portugal: National Institute of Pharmacy and Medicines
Spain: Spanish Agency of Medicines
Austria: Agency for Health and Food Safety
Canada: Ethics Review Committee
Canada: Health Canada
Bulgaria: Bulgarian Drug Agency
Bulgaria: Ministry of Health
Russia: Ethics Committee
Russia: Pharmacological Committee, Ministry of Health
Russia: FSI Scientific Center of Expertise of Medical Application
Turkey: Ethics Committee
Turkey: Ministry of Health
Hong Kong: Ethics Committee
Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee
Malaysia: Ministry of Health
Singapore: Clinical Trials & Epidemiology Research Unit (CTERU)
Singapore: Domain Specific Review Boards
Singapore: Health Sciences Authority
South Korea: Institutional Review Board
South Korea: Korea Food and Drug Administration (KFDA)
Ukraine: Ministry of Health
Ukraine: State Pharmacological Center - Ministry of Health
Slovakia: State Institute for Drug Control
Lithuania: Bioethics Committee
Lithuania: State Medicine Control Agency - Ministry of Health

Keywords provided by Amgen:
zoledronic acid
hematologic malignancies
SRE
skeletal-related event
blood cancer
lytic bone lesions
bone metastases
myeloma
fractures
spinal cord compression
radiation to bone
surgery to bone
bisphosphonates
Neoplasms, Plasma Cell
Paraproteinemias
Neoplasms
Neoplasm Metastasis
Bone Neoplasms
Bone Marrow Diseases
Blood Protein Disorders
Hematologic Diseases
multiple myeloma
denosumab
Neoplastic Processes
Bone Diseases
Diphosphonates
Bone Density Conservation Agents

Additional relevant MeSH terms:
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Bone Diseases
Neoplasms by Histologic Type
Hemostatic Disorders
Vascular Diseases
Cardiovascular Diseases
Paraproteinemias
Blood Protein Disorders
Hematologic Diseases
Hemorrhagic Disorders
Lymphoproliferative Disorders
Immunoproliferative Disorders
Immune System Diseases
Neoplastic Processes
Pathologic Processes
Musculoskeletal Diseases
Zoledronic acid
Diphosphonates
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 18, 2014